Ph.D. (genetics/biochemistry) from the University of Toronto and a MBA from the Asper School of Business.
Career and Professional Development
Andrea Gilpin is currently responsible for all internal and external communications at Theratechnologies, which she joined in 2007. Dr. Gilpin has spent most of her career in the area of Investor Relations in small biotechnologies companies where she was responsible for all investor and shareholder communications. She previously worked at MethylGene, Celmed Biosciences (now Kiadis Pharma), and Nexia Biotechnologies. Over the years, she has also been involved in business development and project/operations management. She also participates on the Canadian Investor Relations Institute Quebec Board of Directors. Andrea holds a Ph.D. (genetics/biochemistry) from the University of Toronto and a MBA from the Asper School of Business. While at the University of Toronto, she organized and ran teacher training workshops for over 10,000 teaching assistants from 80 departments, and designed and initiated a new TA certification program.